Market revenue in 2024 | USD 419.7 million |
Market revenue in 2030 | USD 461.4 million |
Growth rate | 1.6% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.82% in 2024. Horizon Databook has segmented the Germany hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The hospital-acquired infection (HAI) diagnostics market in Germany is experiencing significant growth, driven by an increasing presence of international market players and enhanced access to advanced testing solutions and services.
Companies such as Siemens Healthineers and bioMérieux are prominent players, focusing on innovation and quality to capture market share. The emphasis on early detection and surveillance of HAIs has led to collaborations between hospitals and diagnostic manufacturers to develop tailored solutions that meet specific clinical needs.
Furthermore, Germany's strong emphasis on research funding supports the development of next-generation diagnostic tools, positioning the country as a leader in HAI diagnostics within Europe.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Germany hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account